Bostrycin inhibits proliferation of human lung carcinoma A549 cells via downregulation of the PI3K/Akt pathway
2011

Bostrycin inhibits lung cancer cell growth

publication Evidence: moderate

Author Information

Author(s): Chen Wei-Sheng, Hou Jun-Na, Guo Yu-Biao, Yang Hui-Ling, Xie Can-Mao, Lin Yong-Cheng, She Zhi-Gang

Primary Institution: Sun Yat-Sen University

Hypothesis

This study investigates the inhibitory effects and mechanism of bostrycin on human lung cancer cells in vitro.

Conclusion

Bostrycin significantly inhibits the proliferation of A549 lung cancer cells, potentially through the downregulation of the PI3K/Akt pathway.

Supporting Evidence

  • Bostrycin treatment caused significant inhibition of cell proliferation and induction of apoptosis in A549 cells.
  • Cell cycle arrest was observed in the G0/G1 phase after bostrycin treatment.
  • MicroRNA-638 and microRNA-923 were upregulated in bostrycin-treated cells.
  • Downregulation of p110α and p-Akt/PKB proteins was noted after treatment.
  • Increased activity of p27 protein was observed in treated A549 cells.

Takeaway

Bostrycin is a substance from marine fungi that can stop lung cancer cells from growing and help kill them.

Methodology

The study used MTT assay, flow cytometry, microarray, real-time PCR, and Western blotting to assess the effects of bostrycin on A549 cells.

Limitations

Further studies are necessary to elucidate the mechanisms underlying bostrycin-mediated induction of apoptosis and attenuation of the PI3K/AKT signaling pathway.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1756-9966-30-17

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication